Drug Type Small molecule drug |
Synonyms CPT SR02, CPTSR02 |
Target |
Action modulators |
Mechanism S1PR1 modulators(Sphingosine 1-phosphate receptor Edg-1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Multiple Sclerosis | Preclinical | United States | 01 Jul 2025 | |
| Neuralgia | Preclinical | United States | 01 Jul 2025 |





